Geneos Wealth Management’s Carter Bankshares CARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$89.3K Hold
2,625
﹤0.01% 1253
2026
Q1
$61.2K Hold
2,625
﹤0.01% 1340
2025
Q4
$51.6K Hold
2,625
﹤0.01% 1378
2025
Q3
$51K Hold
2,625
﹤0.01% 1382
2025
Q2
$45.5K Buy
2,625
+1,534
+141% +$24.3K ﹤0.01% 1626
2025
Q1
$17.7K Hold
1,091
﹤0.01% 2004
2024
Q4
$19.2K Hold
1,091
﹤0.01% 1744
2024
Q3
$19K Hold
1,091
﹤0.01% 1580
2024
Q2
$16.5K Hold
1,091
﹤0.01% 1396
2024
Q1
$13.8K Buy
1,091
+591
+118% +$8.05K ﹤0.01% 1466
2023
Q4
$7.49K Hold
500
﹤0.01% 1618
2023
Q3
$6.26K Hold
500
﹤0.01% 1680
2023
Q2
$7.39K Hold
500
﹤0.01% 1650
2023
Q1
$7K Hold
500
﹤0.01% 1641
2022
Q4
$8.29K Hold
500
﹤0.01% 1582
2022
Q3
$8K Sell
500
-220
-31% -$3.44K ﹤0.01% 1564
2022
Q2
$9K Hold
720
﹤0.01% 1974
2022
Q1
$12K Hold
720
﹤0.01% 1998
2021
Q4
$11K Hold
720
﹤0.01% 2127
2021
Q3
$10K Hold
720
﹤0.01% 2209
2021
Q2
$9K Hold
720
﹤0.01% 2223
2021
Q1
$9K Hold
720
﹤0.01% 2410
2020
Q4
$9K Buy
+720
New +$6.12K ﹤0.01% 2243

Other funds holding CARE

Geneos Wealth Management's CARE Position: Q2 2026 in Review

Geneos Wealth Management held its Carter Bankshares (CARE) position steady in Q2 2026 at 2,625 shares worth $89.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1253.

Geneos Wealth Management first reported a position in CARE in Q4 2020 and has held it in 23 quarters since. 163 funds tracked by Wall St. Rank hold CARE as of Q2 2026.

  • Geneos Wealth Management held 2,625 shares of Carter Bankshares worth $89.3K as of Q2 2026.
  • Geneos Wealth Management left its Carter Bankshares share count unchanged in Q2 2026.
  • Carter Bankshares made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #1253 holding.
  • Geneos Wealth Management first reported a position in Carter Bankshares in Q4 2020 and has held it in 23 quarters since.
  • 163 funds tracked by Wall St. Rank held Carter Bankshares as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.